Similar articles

• Screening for prostate cancer.

  Croswell J, Shin YR. Croswell J, et al. Am Fam Physician. 2013 Feb 15;87(4):283-4. Am Fam Physician. 2013. PMID: 23418805 No abstract available.
• Prostate cancer: Prudent practice optimizes screening outcomes.

  Auvinen A. Auvinen A. Nat Rev Urol. 2016 Jul;13(7):376-7. doi: 10.1038/nrurol.2016.90. Epub 2016 May 24. Nat Rev Urol. 2016. PMID: 27215425 Review. No abstract available.
• When to Start Prostate Cancer Screening and When to Stop: Insights from Göteborg.

  Cooperberg M. Cooperberg M. J Urol. 2016 May;195(5):1325-1326. doi: 10.1016/j.juro.2016.02.079. Epub 2016 Feb 18. J Urol. 2016. PMID: 26901508 No abstract available.
• Screening for prostate cancer: the current evidence and guidelines controversy.

  Gomella LG, Liu XS, Trabulsi EJ, Kelly WK, Myers R, Showalter T, Dicker A, Wender R. Gomella LG, et al. Can J Urol. 2011 Oct;18(5):5875-83. Can J Urol. 2011. PMID: 22018148 Review.
• [Analysis of recommendations against prostate cancer screening with prostate specific antigen].

  Abascal Junquera JM, Fumadó Ciutat L, Francés Comalat A, Cecchini Rosell L. Abascal Junquera JM, et al. Med Clin (Barc). 2016 Oct 21;147(8):361-365. doi: 10.1016/j.medcli.2016.03.002. Epub 2016 Apr 13. Med Clin (Barc). 2016. PMID: 27085747 Review. Spanish. No abstract available.